With the year 2020, going with a lot of ups and downs and with a lot of issues and problems, we are not at an end and are about to say the last good-bye to this year that has taught us so many things in so many ways. This year when people were almost locked between the four walls, in their rooms their were a lot of learnings but with that there was also a lot of issues that came up.
A lot of people lost their loves because of the COVID and the pandemic situation made a lot of people lose their family members too. With approaching to a new year and a new year, many of the countries have started giving the permission and have also started to roll out the vaccine in order to get through this pandemic.
India is one among those countries. V G Somani who is the Drug Controller General of India (the DGCI) said on 29th December, Tuesday that our country is likely to have a Covid-19 vaccine in the New Year 2021.
Somani was speaking at a webinar when he said the most important from all the things is that the industry and research organisations have stood to the test of time.
He also said that the vaccine candidates have got their funding and they have also talked about the efforts that were made by the Department of Biotechnology. He further said that he we all Indians would probably have a very happy New Year with something that we are getting in our hand now. The upcoming year would be a lot better in terms of every mean than this yeat. HE said that it is what he can hint at about.
Various institutions of India like the Serum Institute of India, the Bharat Biotech and also the Pfizer have applied to the DCGI. They said that they are looking forward for the emergency use of the authorisation for their Covid-19 vaccine candidates and that they are now waiting to get an approval.
Somani said that the process of the approval was fast-tracked and it was also in the view of the pandemic by quickly making the process for all applications, and hence allowing the parallel phase 1 and 2 trials without waiting for the complete data.
He also said that there has been no compromise done for the safety or for the efficacy of the data. He said that the only thing is that the regulator has been accepted by the partial data.
An expert panel in the Central Drugs Standard Control Organisation who had met on 30th December, Wednesday in order to consider for the emergency use of the authorisation applications by the SII for the Oxford COVID-19 vaccine and also for the ‘Covaxin” which was by the Bharat Biotech will convene again on 1st January so that they can further deliberate for the same matter.
The Subject Expert Committee on 30th December, Wednesday said on Covid-19 that had deliberated and have even analysed the additional data and the information that was submitted by the Serum Institute of India and also by the Bharat Biotech.